Huanjie Yang

5.6k citations

57 papers · 3.8k indexed · 1 hit paper · h-index 32

Complementary and alternative medicine top 0.5%
- Natural Compounds in Disease Treatment 7
Toxicology top 0.5%
Applied Microbiology and Biotechnology top 2%
Cancer Research top 5%
- MicroRNA in disease regulation 5
- Cancer-related molecular mechanisms research 4
Molecular Biology top 5%
- Ubiquitin and proteasome pathways 20
- Natural product bioactivities and synthesis 4
- Cell death mechanisms and regulation 4
Biomedical Engineering
- Nanoplatforms for cancer theranostics 6
Oncology
- Cancer-related Molecular Pathways 5

Co-authors: Q. Ping Dou Di Chen Qiuzhi Cindy Cui Xiao Yuan Kai Li Tak Hang Chan Cheng‐Yan Xu Liang Zhen
Cited by: Complementary and alternative medicine Toxicology Applied Microbiology and Biotechnology
Partner nations: China United States Canada

In The Last Decade

Huanjie Yang

55 papers receiving 3.7k citations

Hit Papers

align trajectories log scale

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

2006 Disulfiram, a Clinically Used Anti-Alcoholism Drug and Copper-Binding Agent, Induces Apoptotic Cell Death in Breast Cancer Cultures and Xenografts via Inhibition of the Proteasome Activity

Peers

Countries citing papers authored by Huanjie Yang

Since Specialization

Citations

This map shows the geographic impact of Huanjie Yang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Huanjie Yang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Huanjie Yang more than expected).

Fields of papers citing papers by Huanjie Yang

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Huanjie Yang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Huanjie Yang. The network helps show where Huanjie Yang may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Huanjie Yang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Huanjie Yang Line = papers co-authored together Huanjie Yang links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Therapeutic repurposing of old drugs to modulate the tumor immune microenvironment and enhance immunotherapy efficacy Yakai Song,Nannan Zheng,Yang Xu,Zhaofan Tao,Qinghui Wang,Zhiyue Cao,Yi Zhang,Mengmeng Li,Ruoyu Mao,Yuhao Chen,Chen Zhao,Huanjie Yang,Bin Yang,Qinghua Ma,Liangcan He,Shaoqin Liu,Kai Li	2025	0
2	Human RSPO1 Mutation Represses Beige Adipocyte Thermogenesis and Contributes to Diet‐Induced Adiposity (Adv. Sci. 12/2023) Yingkai Sun,Juan Zhang,Jie Hong,Zhongyun Zhang,Peng Lü,Aibo Gao,Mengshan Ni,Zhiyong Zhang,Huanjie Yang,Juan Shen,Jieli Lu,Wenzhi Xue,Qianqian Lv,Yufang Bi,Yi Zeng,Weiqiong Gu,Guang Ning,Weiqing Wang,Ruixin Liu,Jiqiu Wang	2023	0
3	miR-33b-3p Acts as a Tumor Suppressor by Targeting DOCK4 in Prostate Cancer Yu Mei,Kai Li,Zhicheng Zhang,Mengmeng Li,Hong Yu Yang,Hui Wang,Xuemei Huang,Xinyuan Li,Shuhua Shi,Huanjie Yang	2021	6
4	Metallothionein-1G suppresses pancreatic cancer cell stemness by limiting activin A secretion via NF-κB inhibition Kai Li,Zhicheng Zhang,Yu Mei,Qingzhu Yang,Shupei Qiao,Cheng Ni,Yao Yao,Xinyuan Li,Mengmeng Li,Dongdong Wei,Wangjun Fu,Xuefei Guo,Xuemei Huang,Huanjie Yang	2021	21
5	Naringenin inhibits pro‑inflammatory cytokine production in macrophages through inducing MT1G to suppress the activation of NF‑κB Yang Jie,Lin Liu,Mengmeng Li,Xuemei Huang,Huanjie Yang,Kai Li	2021	31
6	An Updated Review of Disulfiram: Molecular Targets and Strategies for Cancer Treatment Qingzhu Yang,Yao Yao,Kai Li,Lin Jiao,Jiazhen Zhu,Cheng Ni,Mengmeng Li,Q. Ping Dou,Huanjie Yang	2019	33
7	Linc-DYNC2H1-4 promotes EMT and CSC phenotypes by acting as a sponge of miR-145 in pancreatic cancer cells Yuran Gao,Zhicheng Zhang,Kai Li,Liying Gong,Qingzhu Yang,Xuemei Huang,Chengcheng Hong,Mingfeng Ding,Huanjie Yang	2017	72
8	Biological and Mechanistic Characterization of Novel Prodrugs of Green Tea Polyphenol Epigallocatechin Gallate Analogs in Human Leiomyoma Cell Lines Reda Saber Ibrahim Ahmed,Gang Liu,Andrea Renzetti,Pershang Farshi,Huanjie Yang,Claire Soave,Ghassan M. Saed,Ashraf A. El-Ghoneimy,Hossny A. El-Banna,Robert L. Foldes,Tak Hang Chan,Q. Ping Dou	2016	30
9	Celastrol Induces Autophagy by Targeting AR/miR-101 in Prostate Cancer Cells Jianquan Guo,Xuemei Huang,Hui Wang,Huanjie Yang	2015	67
10	Disulfiram Suppresses Growth of the Malignant Pleural Mesothelioma Cells in Part by Inducing Apoptosis Vino T. Cheriyan,Ying Wang,Magesh Muthu,Shazia Jamal,Di Chen,Huanjie Yang,Lisa Polin,Adi L. Tarca,Harvey I. Pass,Q. Ping Dou,Sunita Sharma,Anil Wali,Arun K. Rishi	2014	40
11	Correction: Withaferin A Inhibits the Proteasome Activity in Mesothelioma In Vitro and In Vivo Huanjie Yang,Ying Wang,Vino T. Cheryan,Wenjuan Wu,Cindy Cui,Lisa Polin,Harvey I. Pass,Q. Ping Dou,Arun K. Rishi,Anil Wali	2013	1
12	Withaferin A Inhibits the Proteasome Activity in Mesothelioma In Vitro and In Vivo Huanjie Yang,Ying Wang,Vino T. Cheryan,Wenjuan Wu,Cindy Cui,Lisa Polin,Harvey I. Pass,Q. Ping Dou,Arun K. Rishi,Anil Wali	2012	52
13	Tumor Cell Growth Inhibition Is Correlated With Levels of Capsaicin Present in Hot Peppers Dan Dou,Aamir Ahmad,Huanjie Yang,Fazlul Sarkar	2011	23
14	Green Tea Polyphenols as Proteasome Inhibitors: Implication in Chemoprevention Huanjie Yang,Kristin R. Landis‐Piwowar,Tak Hang Chan,Q. Ping Dou	2011	57
15	Targeting Tumor Proteasome with Traditional Chinese Medicine Huanjie Yang,Jinbao Liu,Q. Ping Dou	2010	10
16	Calpain‐mediated androgen receptor breakdown in apoptotic prostate cancer cells Huanjie Yang,Shalini Murthy,Fazlul H. Sarkar,Shijie Sheng,G. Prem‐Veer Reddy,Q. Ping Dou	2008	41
17	Disulfiram, a clinically used anti-alcoholism drug and copper-binding agent, induces apoptotic cell death in breast cancer cultures and xenografts via inhibition of the proteasome activity. Di Chen,Qiuzhi Cindy Cui,Huanjie Yang,Q. Ping Dou	2006	17
18	The proteasome as a potential target for novel anticancer drugs and chemosensitizers Kristin R. Landis‐Piwowar,Vesna Milacic,Di Chen,Huanjie Yang,Yunfeng Zhao,Tak Hang Chan,Bing Yan,Q. Ping Dou	2006	123
19	The Tumor Proteasome Is a Primary Target for the Natural Anticancer Compound Withaferin A Isolated from “Indian Winter Cherry” Huanjie Yang,Guoqing Shi,Q. Ping Dou	2006	175
20	P53 transactivates the phosphatase MKP1 through both intronic and exonic p53 responsive elements Huanjie Yang,Gen Sheng Wu	2004	20

About Huanjie Yang

Huanjie Yang is a scholar working on Applied Microbiology and Biotechnology, Complementary and alternative medicine and Cancer Research, having authored 57 papers that have together received 3.8k indexed citations. Recurring topics across this work include Ubiquitin and proteasome pathways (20 papers), Natural Compounds in Disease Treatment (7 papers), Nanoplatforms for cancer theranostics (6 papers), MicroRNA in disease regulation (5 papers), Cancer-related Molecular Pathways (5 papers), Natural product bioactivities and synthesis (4 papers), Cell death mechanisms and regulation (4 papers) and Cancer-related molecular mechanisms research (4 papers). The work is most often cited by research in Complementary and alternative medicine (638 citations), Toxicology (210 citations) and Applied Microbiology and Biotechnology (86 citations). Huanjie Yang has collaborated with scholars based in China, United States and Canada. Frequent co-authors include Q. Ping Dou, Di Chen, Qiuzhi Cindy Cui, Xiao Yuan, Kai Li, Tak Hang Chan, Cheng‐Yan Xu, Liang Zhen, Zhaohua Miao and Kristin R. Landis‐Piwowar.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact